Humidified and standard oxygen therapy in acute severe asthma in children: a randomised controlled pilot trial (HUMOX)
Abstract
Background: Oxygen (O2) is a mainstay of treatment in acute severe asthma. While there are physiological reasons why O2 should be warmed and humidified, how O2 is administered in the UK and Europe varies widely. Aim: To examine whether a trial comparing different humidified O2 to standard O2 is feasible, and specifically obtain data on accrual, adherence and outcome measure stability. Methods: Children 2-16yrs attending AE 23, 6-16yrs) recruited at 4 sites. See Table for results; all data are mean (95%CI). ASS decreased in all three groups similarly following randomisation. Conclusions: This is the first RCT to compare humidified and standard O2 therapy in acute severe asthma in children. With the caveat that these are pilot data, children treated with heated humidified O2 received more nebulised treatment and were more likely to have their treatment escalated. These findings and accompanying screening data will inform a future definitive clinical trial.
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Characterization and Analysis of Porosity and Pore Structures
- Practical considerations for conducting ecotoxicity test methods with manufactured nanomaterials: what have we learnt so far?
- Dental Optical Coherence Tomography
- Radiation-shielding concrete: A review of materials, performance, and the impact of radiation on concrete properties
- Testing entanglement of annihilation photons
- Calanus finmarchicus seasonal cycle and diapause in relation to gene expression, physiology, and endogenous clocks
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.